Nab-paclitaxel and carboplatin combined with antiangiogenic drugs
收藏NIAID Data Ecosystem2026-03-11 收录
官方服务：
资源简介：
We retrospectively investigated the efficacy and toxicity of NCA regimen in unresectable stage IIIC or IV melanoma patients who progressed on previous therapy. The NCA regimen consisted of nab-paclitaxel (260 mg/m2) and carboplatin(AUC=5) on day 1 and bevacizumab, 5 mg/kg IV every 2 weeks or endostatin 7.5mg/m2 days 1-14,Q28.
创建时间：
2020-03-05
